{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:57:46Z","timestamp":1789588666905,"version":"build-2803163510"},"reference-count":98,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Ensign Endowment for Gynecologic Cancer Research"},{"name":"American Cancer Society Research Professor Award"},{"DOI":"10.13039\/100013028","name":"Frank McGraw Memorial Chair in Cancer Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100013028","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.ygyno.2017.10.026","type":"journal-article","created":{"date-parts":[[2017,11,11]],"date-time":"2017-11-11T04:15:14Z","timestamp":1510373714000},"page":"222-232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Aspirin use and endometrial cancer risk and survival"],"prefix":"10.1016","volume":"148","author":[{"given":"Tsuyoshi","family":"Takiuchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin A.","family":"Blake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil K.","family":"Sood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore M.","family":"Brasky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2017.10.026_bb0005","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.jacc.2016.05.083","article-title":"Aspirin and cancer","volume":"68","author":"Patrignani","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ygyno.2017.10.026_bb0010","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials","volume":"373","author":"Baigent","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2017.10.026_bb0015","doi-asserted-by":"crossref","first-page":"836","DOI":"10.7326\/M16-0577","article-title":"Aspirin use for the primary prevention of cardiovascular disease and colorectal cancer: U.S. preventive services task force recommendation statement","volume":"164","author":"Bibbins-Domingo","year":"2016","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ygyno.2017.10.026_bb0020","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0140-6736(10)61543-7","article-title":"Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials","volume":"376","author":"Rothwell","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2017.10.026_bb0025","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/S0140-6736(12)60209-8","article-title":"Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials","volume":"379","author":"Rothwell","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2017.10.026_bb0030","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(10)62110-1","article-title":"Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials","volume":"377","author":"Rothwell","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2017.10.026_bb0035","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1053\/j.seminoncol.2015.09.010","article-title":"Mechanisms of nonsteroidal anti-inflammatory drugs in cancer prevention","volume":"43","author":"Umar","year":"2016","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.ygyno.2017.10.026_bb0040","author":"The Surveillance E, and End Results (SEER) Program of the National Cancer Institute"},{"key":"10.1016\/j.ygyno.2017.10.026_bb0045","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ygyno.2015.08.022","article-title":"Associations between etiologic factors and mortality after endometrial cancer diagnosis: the NRG Oncology\/Gynecologic Oncology Group 210 trial","volume":"139","author":"Felix","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.10.026_bb0050","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1093\/annonc\/mdw310","article-title":"The obese endometrial cancer patient: how do we effectively improve morbidity and mortality in this patient population?","volume":"27","author":"Papatla","year":"2016","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ygyno.2017.10.026_bb0055","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.ajog.2011.05.042","article-title":"Understanding obesity and endometrial cancer risk: opportunities for prevention","volume":"205","author":"Schmandt","year":"2011","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2017.10.026_bb0060","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1002\/cncr.30094","article-title":"Endometrial cancer: not your grandmother's cancer","volume":"122","author":"McAlpine","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2017.10.026_bb0065","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0090-8258(83)90111-7","article-title":"Two pathogenetic types of endometrial carcinoma","volume":"15","author":"Bokhman","year":"1983","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.10.026_bb0070","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1200\/JCO.2012.48.2596","article-title":"Type I and II endometrial cancers: have they different risk factors?","volume":"31","author":"Setiawan","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2017.10.026_bb0075","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/S0140-6736(13)61649-9","article-title":"Colorectal cancer","volume":"383","author":"Brenner","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2017.10.026_bb0080","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","article-title":"Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults","volume":"348","author":"Calle","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2017.10.026_bb0085","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.bbalip.2013.02.010","article-title":"Adipose tissue and adipocytes support tumorigenesis and metastasis","volume":"1831","author":"Nieman","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ygyno.2017.10.026_bb0090","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/978-3-319-42542-9_7","article-title":"Obesity and endometrial cancer","volume":"208","author":"Shaw","year":"2016","journal-title":"Recent Results Cancer Res."},{"key":"10.1016\/j.ygyno.2017.10.026_bb0095","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3233\/CBM-2011-0167","article-title":"Molecular pathogenesis of endometrial and ovarian cancer","volume":"9","author":"Merritt","year":"2010","journal-title":"Cancer Biomark"},{"key":"10.1016\/j.ygyno.2017.10.026_bb0100","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/ijc.28679","article-title":"Activation of a positive feedback loop involving IL-6 and aromatase promotes intratumoral 17beta-estradiol biosynthesis in endometrial carcinoma microenvironment","volume":"135","author":"Che","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2017.10.026_bb0105","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1749-6632.2011.06096.x","article-title":"The growing challenge of obesity and cancer: an inflammatory issue","volume":"1229","author":"Harvey","year":"2011","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ygyno.2017.10.026_bb0110","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/CEJ.0b013e32835b3813","article-title":"Case-control study of inflammatory markers and the risk of endometrial cancer","volume":"22","author":"Friedenreich","year":"2013","journal-title":"Eur. J. Cancer Prev."},{"key":"10.1016\/j.ygyno.2017.10.026_bb0115","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1158\/1055-9965.EPI-10-1222","article-title":"Prospective study of inflammation markers and endometrial cancer risk in postmenopausal hormone nonusers","volume":"20","author":"Wang","year":"2011","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.ygyno.2017.10.026_bb0120","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.matbio.2013.09.002","article-title":"Cross-talk between estradiol receptor and EGFR\/IGF-IR signaling pathways in estrogen-responsive breast cancers: focus on the role and impact of proteoglycans","volume":"35","author":"Skandalis","year":"2013","journal-title":"Matrix Biol."},{"key":"10.1016\/j.ygyno.2017.10.026_bb0125","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1349-7006.2008.01053.x","article-title":"Leptin induces functional activation of cyclooxygenase-2 through JAK2\/STAT3, MAPK\/ERK, and PI3K\/AKT pathways in human endometrial cancer cells","volume":"100","author":"Gao","year":"2009","journal-title":"Cancer Sci."},{"key":"10.1016\/j.ygyno.2017.10.026_bb0130","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s11912-013-0351-3","article-title":"Role of aspirin in cancer prevention","volume":"15","author":"Thorat","year":"2013","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.ygyno.2017.10.026_bb0135","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1056\/NEJM198411083111902","article-title":"Dose-related kinetics of aspirin. Presystemic acetylation of platelet cyclooxygenase","volume":"311","author":"Pedersen","year":"1984","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2017.10.026_bb0140","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/89759","article-title":"Lipid mediator class switching during acute inflammation: signals in resolution","volume":"2","author":"Levy","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ygyno.2017.10.026_bb0145","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejphar.2015.03.083","article-title":"Lipoxins and aspirin-triggered lipoxins in resolution of inflammation","volume":"760","author":"Romano","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ygyno.2017.10.026_bb0150","doi-asserted-by":"crossref","first-page":"15178","DOI":"10.1073\/pnas.0405445101","article-title":"Aspirin triggers antiinflammatory 15-epi-lipoxin A4 and inhibits thromboxane in a randomized human trial","volume":"101","author":"Chiang","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ygyno.2017.10.026_bb0155","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/978-3-642-30331-9_3","article-title":"Mode of action of aspirin as a chemopreventive agent","volume":"191","author":"Dovizio","year":"2013","journal-title":"Recent Results Cancer Res."},{"key":"10.1016\/j.ygyno.2017.10.026_bb0160","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1111\/jth.12637","article-title":"Reappraisal of the clinical pharmacology of low-dose aspirin by comparing novel direct and traditional indirect biomarkers of drug action","volume":"12","author":"Patrignani","year":"2014","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.ygyno.2017.10.026_bb0165","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ygyno.2015.12.009","article-title":"Non-steroidal anti-inflammatory drug use and risk of endometrial cancer: a systematic review and meta-analysis of observational studies","volume":"140","author":"Verdoodt","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.10.026_bb0170","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrclinonc.2011.199","article-title":"The role of aspirin in cancer prevention","volume":"9","author":"Thun","year":"2012","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2017.10.026_bb0175","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1158\/1940-6207.CAPR-16-0094","article-title":"Inhibition of the biosynthesis of prostaglandin E2 by low-dose aspirin: implications for adenocarcinoma metastasis","volume":"9","author":"Boutaud","year":"2016","journal-title":"Cancer Prev. Res. (Phila.)"},{"key":"10.1016\/j.ygyno.2017.10.026_bb0180","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.plefa.2004.10.006","article-title":"Platelet activation in patients with colorectal cancer","volume":"72","author":"Sciulli","year":"2005","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.ygyno.2017.10.026_bb0185","first-page":"383","article-title":"A novel mechanism for aspirin-mediated growth inhibition of human colon cancer cells","volume":"9","author":"Goel","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2017.10.026_bb0190","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1056\/NEJMoa067208","article-title":"Aspirin and the risk of colorectal cancer in relation to the expression of COX-2","volume":"356","author":"Chan","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2017.10.026_bb0195","first-page":"597","article-title":"Aspirin inhibits camptothecin-induced p21CIP1 levels and potentiates apoptosis in human breast cancer cells","volume":"34","author":"Alfonso","year":"2009","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ygyno.2017.10.026_bb0200","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S1470-2045(09)70035-X","article-title":"Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement","volume":"10","author":"Cuzick","year":"2009","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2017.10.026_bb0205","first-page":"423","article-title":"Aspirin effects on endometrial cancer cell growth","volume":"97","author":"Arango","year":"2001","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2017.10.026_bb0210","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrc2809","article-title":"Eicosanoids and cancer","volume":"10","author":"Wang","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ygyno.2017.10.026_bb0215","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1054\/bjoc.2001.2033","article-title":"Expression of COX-2 and PGE synthase and synthesis of PGE(2)in endometrial adenocarcinoma: a possible autocrine\/paracrine regulation of neoplastic cell function via EP2\/EP4 receptors","volume":"85","author":"Jabbour","year":"2001","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2017.10.026_bb0220","doi-asserted-by":"crossref","first-page":"6272","DOI":"10.1210\/en.2008-0352","article-title":"Synergistic up-regulation of prostaglandin E synthase expression in breast cancer cells by 17beta-estradiol and proinflammatory cytokines","volume":"149","author":"Frasor","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.ygyno.2017.10.026_bb0225","doi-asserted-by":"crossref","first-page":"26208","DOI":"10.1074\/jbc.M201347200","article-title":"Up-regulation of cyclooxygenase-2 expression and prostaglandin synthesis in endometrial stromal cells by malignant endometrial epithelial cells. A paracrine effect mediated by prostaglandin E2 and nuclear factor-kappa B","volume":"277","author":"Tamura","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ygyno.2017.10.026_bb0230","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0092-8674(00)81433-6","article-title":"Cyclooxygenase regulates angiogenesis induced by colon cancer cells","volume":"93","author":"Tsujii","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.ygyno.2017.10.026_bb0235","doi-asserted-by":"crossref","first-page":"12203","DOI":"10.1007\/s13277-016-5087-x","article-title":"Prostaglandin E2 (PGE2) promotes proliferation and invasion by enhancing SUMO-1 activity via EP4 receptor in endometrial cancer","volume":"37","author":"Ke","year":"2016","journal-title":"Tumour Biol."},{"key":"10.1016\/j.ygyno.2017.10.026_bb0240","first-page":"753","article-title":"Clinicopathologic and prognostic significance of cyclooxygenase-2 expression in endometrial carcinoma","volume":"20","author":"Lambropoulou","year":"2005","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.ygyno.2017.10.026_bb0245","doi-asserted-by":"crossref","first-page":"6112","DOI":"10.1210\/jc.2004-0892","article-title":"Prostaglandin E2 mediates phosphorylation and down-regulation of the tuberous sclerosis-2 tumor suppressor (tuberin) in human endometrial adenocarcinoma cells via the Akt signaling pathway","volume":"89","author":"Sales","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ygyno.2017.10.026_bb0250","doi-asserted-by":"crossref","first-page":"5739","DOI":"10.1210\/endo.137.12.8940410","article-title":"Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene","volume":"137","author":"Zhao","year":"1996","journal-title":"Endocrinology"},{"key":"10.1016\/j.ygyno.2017.10.026_bb0255","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1007\/s13277-013-0991-9","article-title":"Altered expression of ERs, aromatase, and COX2 connected to estrogen action in type 1 endometrial cancer biology","volume":"34","author":"Jarzabek","year":"2013","journal-title":"Tumour Biol."},{"key":"10.1016\/j.ygyno.2017.10.026_bb0260","doi-asserted-by":"crossref","first-page":"32462","DOI":"10.18632\/oncotarget.8655","article-title":"Aspirin prevents colorectal cancer metastasis in mice by splitting the crosstalk between platelets and tumor cells","volume":"7","author":"Guillem-Llobat","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ygyno.2017.10.026_bb0265","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1124\/mol.113.084988","article-title":"Pharmacological inhibition of platelet-tumor cell cross-talk prevents platelet-induced overexpression of cyclooxygenase-2 in HT29 human colon carcinoma cells","volume":"84","author":"Dovizio","year":"2013","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ygyno.2017.10.026_bb0270","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ab.2004.08.019","article-title":"Quantification of the major urinary metabolite of PGE2 by a liquid chromatographic\/mass spectrometric assay: determination of cyclooxygenase-specific PGE2 synthesis in healthy humans and those with lung cancer","volume":"334","author":"Murphey","year":"2004","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ygyno.2017.10.026_bb0275","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/sj.bjp.0706013","article-title":"Platelet\u2013cancer interactions: mechanisms and pharmacology of tumour cell-induced platelet aggregation","volume":"143","author":"Jurasz","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ygyno.2017.10.026_bb0280","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMoa1110352","article-title":"Paraneoplastic thrombocytosis in ovarian cancer","volume":"366","author":"Stone","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2017.10.026_bb0285","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.ygyno.2013.08.032","article-title":"Preoperative anemia, leukocytosis and thrombocytosis identify aggressive endometrial carcinomas","volume":"131","author":"Njolstad","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.10.026_bb0290","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Kandoth","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ygyno.2017.10.026_bb0295","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1016\/j.ejca.2015.07.012","article-title":"Venous thromboembolism, interleukin-6 and survival outcomes in patients with advanced ovarian clear cell carcinoma","volume":"51","author":"Matsuo","year":"2015","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ygyno.2017.10.026_bb0300","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/095371002220148332","article-title":"Mean platelet volume as an indicator of platelet activation: methodological issues","volume":"13","author":"Park","year":"2002","journal-title":"Platelets"},{"key":"10.1016\/j.ygyno.2017.10.026_bb0305","doi-asserted-by":"crossref","first-page":"4905","DOI":"10.7314\/APJCP.2015.16.12.4905","article-title":"Relations of platelet indices with endometrial hyperplasia and endometrial cancer","volume":"16","author":"Karateke","year":"2015","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.ygyno.2017.10.026_bb0310","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.7314\/APJCP.2014.15.8.3741","article-title":"Overexpression of platelet-derived growth factor-D as a poor prognosticator in endometrial cancer","volume":"15","author":"Ding","year":"2014","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.ygyno.2017.10.026_bb0315","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1056\/NEJMoa1207756","article-title":"Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival","volume":"367","author":"Liao","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2017.10.026_bb0320","first-page":"4047","article-title":"Expression of Tn and sialyl-Tn antigens in endometrial cancer: its relationship with tumor-produced cyclooxygenase-2, tumor-infiltrated lymphocytes and patient prognosis","volume":"26","author":"Ohno","year":"2006","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ygyno.2017.10.026_bb0325","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/AOG.0000000000000926","article-title":"Association between statin use and endometrial cancer survival","volume":"126","author":"Nevadunsky","year":"2015","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2017.10.026_bb0330","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1525-1438.2007.00867.x","article-title":"Exploring the potential chemopreventative effect of aspirin and rofecoxib on hereditary nonpolyposis colorectal cancer-like endometrial cancer cells in vitro through mechanisms involving apoptosis, the cell cycle, and mismatch repair gene expression","volume":"17","author":"Wood","year":"2007","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2017.10.026_bb0335","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/AOG.0000000000001491","article-title":"Association of low-dose aspirin and survival of women with endometrial cancer","volume":"128","author":"Matsuo","year":"2016","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2017.10.026_bb0340","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.canlet.2007.05.008","article-title":"Influences of cyclooxygenase-1 and -2 expression on the radiosensitivities of human cervical cancer cell lines","volume":"256","author":"Jeon","year":"2007","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ygyno.2017.10.026_bb0345","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0140-6736(92)93216-A","article-title":"Low-dose aspirin and subsequent peripheral arterial surgery in the Physicians' Health Study","volume":"340","author":"Goldhaber","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2017.10.026_bb0350","doi-asserted-by":"crossref","first-page":"699","DOI":"10.4161\/cbt.28554","article-title":"Aspirin improves outcome in high risk prostate cancer patients treated with radiation therapy","volume":"15","author":"Jacobs","year":"2014","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.ygyno.2017.10.026_bb0355","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1172\/JCI80006","article-title":"Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophages","volume":"125","author":"Ugel","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ygyno.2017.10.026_bb0360","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ygyno.2014.08.028","article-title":"Prognostic significance of tumor-associated macrophages in endometrial adenocarcinoma","volume":"135","author":"Kubler","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.10.026_bb0365","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1093\/carcin\/bgt009","article-title":"Low-dose aspirin delays an inflammatory tumor progression in vivo in a transgenic mouse model of neuroblastoma","volume":"34","author":"Carlson","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ygyno.2017.10.026_bb0370","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S1470-2045(12)70112-2","article-title":"Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials","volume":"13","author":"Algra","year":"2012","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2017.10.026_bb0375","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/S0140-6736(11)61720-0","article-title":"Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials","volume":"379","author":"Rothwell","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2017.10.026_bb0380","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.294.1.47","article-title":"Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial","volume":"294","author":"Cook","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2017.10.026_bb0385","doi-asserted-by":"crossref","first-page":"77","DOI":"10.7326\/0003-4819-159-2-201307160-00002","article-title":"Alternate-day, low-dose aspirin and cancer risk: long-term observational follow-up of a randomized trial","volume":"159","author":"Cook","year":"2013","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ygyno.2017.10.026_bb0390","first-page":"973","article-title":"Use of nonsteroidal anti-inflammatory drugs and risk of endometrial cancer: a nationwide case-control study","volume":"26","author":"Brons","year":"2015","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.ygyno.2017.10.026_bb0395","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1002\/ijc.27717","article-title":"Aspirin, nonsteroidal anti-inflammatory drugs, paracetamol and risk of endometrial cancer: a case-control study, systematic review and meta-analysis","volume":"132","author":"Neill","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2017.10.026_bb0400","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gore.2016.04.007","article-title":"Aspirin and endometrial cancer risk","volume":"17","author":"Brasky","year":"2016","journal-title":"Gynecol. Oncol. Rep."},{"key":"10.1016\/j.ygyno.2017.10.026_bb0405","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ygyno.2012.10.005","article-title":"Non-steroidal anti-inflammatory drugs and endometrial cancer risk in the VITamins And Lifestyle (VITAL) cohort","volume":"128","author":"Brasky","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.10.026_bb0410","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/S0140-6736(11)61049-0","article-title":"Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial","volume":"378","author":"Burn","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2017.10.026_bb0415","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jnci\/djw251","article-title":"Nonsteroidal anti-inflammatory drugs and endometrial carcinoma mortality and recurrence","volume":"109","author":"Brasky","year":"2017","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2017.10.026_bb0420","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/bjc.2017.207","article-title":"Commonly used medications and endometrial cancer survival: a population-based cohort study","volume":"117","author":"Sanni","year":"2017","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2017.10.026_bb0425","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ygyno.2011.03.010","article-title":"Insurance status and racial differences in uterine cancer survival: a study of patients in the National Cancer Database","volume":"122","author":"Fedewa","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.10.026_bb0430","doi-asserted-by":"crossref","unstructured":"McQuaid KR, Laine L. Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials. Am. J. Med. l2006;119: 624\u201338.","DOI":"10.1016\/j.amjmed.2005.10.039"},{"key":"10.1016\/j.ygyno.2017.10.026_bb0435","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(02)07272-0","article-title":"Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial","volume":"359","author":"Chan","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2017.10.026_bb0440","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1046\/j.0306-5251.2001.01476.x","article-title":"Association between aspirin and upper gastrointestinal complications: systematic review of epidemiologic studies","volume":"52","author":"Garcia Rodriguez","year":"2001","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ygyno.2017.10.026_bb0445","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1161\/CIRCULATIONAHA.114.008828","article-title":"Aspirin for the prevention of recurrent venous thromboembolism: the INSPIRE collaboration","volume":"130","author":"Simes","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.ygyno.2017.10.026_bb0450","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.ygyno.2012.12.014","article-title":"Predictive model of venous thromboembolism in endometrial cancer","volume":"128","author":"Matsuo","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.10.026_bb0455","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1158\/1535-7163.MCT-16-0074","article-title":"Antitumor and antiangiogenic effects of aspirin-PC in ovarian cancer","volume":"15","author":"Huang","year":"2016","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ygyno.2017.10.026_bb0460","doi-asserted-by":"crossref","first-page":"7","DOI":"10.5009\/gnl.2013.7.1.7","article-title":"Advent of novel phosphatidylcholine-associated nonsteroidal anti-inflammatory drugs with improved gastrointestinal safety","volume":"7","author":"Lim","year":"2013","journal-title":"Gut Liver"},{"key":"10.1016\/j.ygyno.2017.10.026_bb0465","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1161\/01.CIR.87.5.1482","article-title":"Does obesity influence early target organ damage in hypertensive patients?","volume":"87","author":"Schmieder","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.ygyno.2017.10.026_bb0470","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0140-6736(98)04311-6","article-title":"Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group","volume":"351","author":"Hansson","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2017.10.026_bb0475","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.ejca.2012.10.024","article-title":"Use of aspirin post-diagnosis in a cohort of patients with colorectal cancer and its association with all-cause and colorectal cancer specific mortality","volume":"49","author":"McCowan","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ygyno.2017.10.026_bb0480","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1136\/gutjnl-2014-308260","article-title":"Aspirin use after diagnosis but not prediagnosis improves established colorectal cancer survival: a meta-analysis","volume":"64","author":"Li","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.ygyno.2017.10.026_bb0485","article-title":"End-of-life prescribing of aspirin in patients with breast or colorectal cancer","author":"Murphy","year":"2017","journal-title":"BMJ Support. Palliat. Care"},{"key":"10.1016\/j.ygyno.2017.10.026_bb0490","doi-asserted-by":"crossref","first-page":"4326","DOI":"10.1096\/fj.11-187658","article-title":"Lipoxin A4 is a novel estrogen receptor modulator","volume":"25","author":"Russell","year":"2011","journal-title":"FASEB J."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825817314488?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825817314488?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:37:22Z","timestamp":1758771442000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825817314488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":98,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0090825817314488"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2017.10.026","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aspirin use and endometrial cancer risk and survival","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2017.10.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}